Qube Research & Technologies LTD Albireo Pharma, Inc. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$18.54 - $37.29 $1 Million - $2.01 Million	54,015 New	54,015 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $380,203 - $507,901	-12,047 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$23.19 - $41.61 $279,369 - $501,275	12,047 New	12,047 $402,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.